Scientists have identified a group of rare and dangerous brain tumors that occur in less than 1 percent of the general population.
The tumors can cause irreversible damage to the brain, and their symptoms are sometimes described as “brain fog.”
Now, a group that studies rare brain tumors is offering a simple, affordable way to treat the condition.
The American Brain Tumor Foundation says its brain tumor drug can be administered to people in the U.S. and other countries for about $2 a pill, or by mail, without requiring a doctor’s appointment.
The foundation, which promotes research in the field, also hopes to bring its drug to other countries.
The drug works by mimicking the effects of chemotherapy and the drugs used to treat it.
The research team said in a statement that it has used brain tumor drugs in mice, but has not tested them on humans.
It also noted that the drug has the potential to prevent the onset of brain tumors, which can cause permanent damage to brain cells.
The treatment is more efficient and less invasive than traditional chemotherapy.
The disease affects about 2 percent of people and is thought to be caused by a mutation of a gene in a gene called CREB that encodes a protein that helps cells divide.
The gene mutation was first identified in an unrelated patient who developed a form of the disease in the 1990s, but the disease remained rare until now.
About 200,000 people in North America and more than 5 million people worldwide have the disease, which is caused by abnormal cell growth.
The brain is the first place in the body where this abnormal growth can occur.
The immune system can attack the cells and kill them.
Some of the brain tumors are relatively small, but many are larger.
The new drug, called MRL-1235, targets CREB by mimicking the gene in question and is currently being tested on mice.
It has been approved for use in patients with a severe form of brain tumor, according to the foundation.
It is expected to be available in the first half of 2020.
Brain tumors can also occur in the kidneys and liver, but these tumors are rare.